OFIX — Orthofix Medical Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 884624 ·
Last close
$6.67
Market Cap
$271.87M
52W High
$16.42
52W Low
$6.52
ADV30
584,508
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 207,862,000 | 146,546,000 | 2,941,000 | -6,074,000 | 855,761,000 | 86,322,000 | 426,194,000 |
| Jun 2026 | 210,933,000 | 149,707,000 | -7,266,000 | -15,798,000 | 873,020,000 | 103,810,000 | 443,840,000 |
| Mar 2026 | 196,708,000 | 139,546,000 | -13,686,000 | -20,908,000 | 886,601,000 | 120,278,000 | 451,415,000 |
| Dec 2025 | 219,911,000 | 156,342,000 | 1,154,000 | -2,222,000 | 850,647,000 | 82,025,000 | 400,610,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,226,000
Investing CF
$-48,535,000
Financing CF
$65,605,000
CapEx
$-48,687,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.12
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-411,113,000
Inventory
$190,357,000
Receivables
$131,719,000
ST Investments
—
EBIT TTM
$-18,982,000
Pretax Income TTM
$-43,271,000
Interest Exp TTM
$20,781,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$835,414,016
EBITDA
$41,077,000
Free Cash Flow
$-20,739,876
Enterprise Value
$468,011,776
Total Cash
$86,322,000
Total Debt
$262,086,000
Shares Out
40,759,801
Trailing EPS
$-1.10
Book Value
$10.54
ROE
-10.3%
ROA
-1.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 822,312,000 | -82,568,000 | -92,192,000 | 850,647,000 | 400,610,000 | 450,037,000 | 33,347,000 |
| Dec 2024 | 799,491,000 | -77,719,000 | -125,997,000 | 893,294,000 | 390,170,000 | 503,124,000 | 25,790,000 |
| Dec 2023 | 746,641,000 | -141,761,000 | -151,395,000 | 925,315,000 | 326,585,000 | 598,730,000 | -45,753,000 |
| Dec 2022 | 460,713,000 | -28,868,000 | -19,749,000 | 458,629,000 | 121,769,000 | 336,860,000 | -11,538,000 |
TTM Snapshot
Revenues TTM
$833,186,000
NetIncome TTM
$-61,723,000
OpCashFlow TTM
—
Assets (Latest)
$873,020,000
Forward EPS
$0.18
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $6.61 · call volume: 56 · put volume: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SSII | SS Innovations International, Inc. | $266.51M | $1.33 | — |
| NPCE | NeuroPace Inc | $282.50M | $8.20 | — |
| PROF | Profound Medical Corp. | $259.32M | $7.08 | — |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $288.75M | $4.44 | — |
| CLPT | ClearPoint Neuro, Inc. | $251.95M | $7.86 | — |
News headlines (Yahoo Finance, 1h cache)
Orthofix (OFIX) Upgraded to Buy: What Does It Mean for the Stock?
2026-11-18 16:00 · Yahoo
Orthofix Medical (OFIX) Stock Sees Fair Value Cut After Analysts Rework Q3 Risks
2026-11-16 14:10 · Yahoo
Orthofix Medical Inc. Q3 2026 Earnings Call Summary
2026-11-09 17:44 · Yahoo
Orthofix Medical Q3 Earnings Call Highlights
2026-11-09 17:15 · Yahoo
Orthofix Medical (OFIX) Q3 2026 Earnings Call Transcript
2026-11-09 17:13 · Yahoo
Orthofix (OFIX) Surpasses Q3 Earnings Estimates
2026-11-09 12:25 · Yahoo
Orthofix: Q3 Earnings Snapshot
2026-11-09 12:16 · Yahoo
Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance
2026-11-09 12:00 · Yahoo
Orthofix (OFIX) Surges 11.0%: Is This an Indication of Further Gains?
2026-11-05 11:50 · Yahoo
Orthofix to Report Third Quarter 2026 Financial Results
2026-10-23 20:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.